Opendata, web and dolomites

CL_Exocytosis SIGNED

“Molecular dissection of cytotoxic lymphocyte exocytosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CL_Exocytosis project word cloud

Explore the words cloud of the CL_Exocytosis project. It provides you a very rough idea of what is the project "CL_Exocytosis" about.

plasma    endosome    plan    disorders    severe    motivated    diagnosis    vesicular    mutations    components    critical    regulated    mass    expertise    cargo    isoforms    quantitative    exocytosis    insights    healthy    purse    prompted    cytosolic    me    cytotoxicity    syndromes    molecule    successfully    hyperinflammatory    genetic    interaction    profoundly    context    life    live    deciphering    expand    immune    guide    proteins    promise    cooperate    lymphocyte    successful    human    lab    contribution    molecular    dr    move    phd    offers    yearning    explore    membrane    11    defects    granule    constituents    onset    strategies    delivering    mechanistic    host    scientific    bryceson    fusion    disease    activation    career    cytotoxic    horizon    spectrometry    cl    dissecting    imaging    munc13    cell    laboratory    recycling    limited    syntaxin    therapy    re    cg    effector    throughput    immunology    my    implicated    genes    excellence    gain    pathological    underlying    academic    exocytic    opportunity    ms    first    regulation    causative   

Project "CL_Exocytosis" data sheet

The following table provides information about the project.

Coordinator
KAROLINSKA INSTITUTET 

Organization address
address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177
website: www.ki.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 173˙857 €
 EC max contribution 173˙857 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2020-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KAROLINSKA INSTITUTET SE (STOCKHOLM) coordinator 173˙857.00

Map

 Project objective

My PhD experience in the field of immunology focused on deciphering vesicular pathways underlying T cell activation profoundly motivated my move to Dr. Bryceson’s lab, which offers a unique opportunity to explore cytotoxic lymphocyte (CL) exocytosis in the context of human disease. Cytotoxic lymphocyte exocytosis is critical for life, with mutations in genes required for cytotoxicity causative of severe, early-onset hyperinflammatory syndromes. Genetic studies have identified several cytosolic proteins required for CL exocytosis. However, understanding of how these proteins cooperate for exocytosis, their interaction partners and how their activities are regulated is still limited. I propose strategies to gain insight to the molecular regulation of human CL exocytosis. First, prompted by genetic studies, I aim to study the contribution of two distinct Munc13-4 isoforms to lymphocyte cytotoxicity by dissecting their role in cytotoxic granule (CG) exocytosis using advanced live-cell imaging as well as identifying their interaction partners using quantitative mass spectrometry (MS). Second, recycling endosome (RE) have recently been implicated in CG exocytosis, delivering syntaxin-11, an effector molecule required for CG fusion, to the plasma membrane. I plan to use a high-throughput MS approach to identify RE constituents and cargo in order to define new components that may be critical for CG exocytosis. Results will provide novel mechanistic insights to CL exocytosis, which will also be relevant for other exocytic systems. Providing detailed molecular understanding of lymphocyte cytotoxicity in both healthy and pathological conditions, insights promise to guide improved diagnosis and therapy of immune disorders associated with defects in lymphocyte cytotoxicity. Yearning to build a successful academic career, the excellence of the host laboratory will allow me to successfully purse this project and expand technical expertise and my scientific horizon.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CL_EXOCYTOSIS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CL_EXOCYTOSIS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

EMPaTHY (2019)

use of multiscale modElling to Minimize coke ProducTion during the methanol-to- HYdrocarbon process

Read More  

WONDER (2019)

Low-Bandgap Fused Ring Electron Acceptors towards High-Efficiency Organic Solar Cells

Read More  

STIMOS (2019)

Stimulation of Multiple Organoids Simultaneously

Read More